Omeros Corp (NAS:OMER) Stock News, Headlines & Updates
Omeros Corp Stock News from GuruFocus
- 1
Feb 23, 2025
INGALLS & SNYDER LLC Reduces Stake in Omeros Corp: A Strategic Portfolio Adjustment
GuruFocus News • 5:54am
Feb 20, 2025
Omeros Announces Robust Results for Narsoplimab Expanded Access Program in TA-TMA
Business Wire • 9:00am
Feb 14, 2025
Omeros Corporation Announces Availability on its Website of Materials Accompanying Narsoplimab Presentations at the 2025 Tandem Meetings
Business Wire • 9:00am
Feb 10, 2025
Omeros Corporation Announces Upcoming Presentations Detailing Outcomes of Narsoplimab Treatment for TA-TMA Under an Expanded Access Program
Business Wire • 9:00am
Jan 16, 2025
Omeros Announces Update on Statistical Analysis of Narsoplimab Pivotal Trial Primary Endpoint
Business Wire • 9:00am
Dec 19, 2024
Omeros Reports Narsoplimab TA-TMA Trial Success; Stock Surges
Faizan Farooque • 9:46am
Omeros' Narsoplimab Meets its Pivotal Trial Primary Endpoint -- Statistical Analysis Shows Survival Superiority Over External Control in Patients with TA-TMA
Business Wire • 9:00am
Dec 11, 2024
Omeros Corporation (OMER) Stock Drops Amid Financial Report Concerns
GuruFocus News • 2:51pm
Dec 10, 2024
Omeros Corporation Announces Presentation of Positive Zaltenibart Data at ASH Annual Meeting
Business Wire • 8:00am
Dec 04, 2024
Omeros Corporation (OMER) Stock Surges Amidst Biotech Sector Gains
GuruFocus News • 2:50pm
- 1
Show
Entries
Headlines
Total 0- 1
No recent news